Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation

Universitaire Ziekenhuizen KU Leuven45 enrolled

Overview

Evaluation of the response to chemotherapy in breast cancer patients by the use of Diffusion-weighted magnetic resonance imaging of the breast before the start of chemotherapy, after one and 3 cycles of therapy and at the end of the therapy.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Breast Cancer

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * core biopsy with diagnosis of breast cancer * start of neo-adjuvant chemotherapy Exclusion Criteria: * magnetic resonance imaging incompatibility

Locations (1)

University Hospitals Leuven

Leuven, Belgium

Outcomes

Primary Outcomes

Response to chemotherapy

outcome is the results of pathology after chemotherapy and surgery. Data will be collected for a period of 1 year.

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.